Key Metrics
MARKET CAP
$81.49B
P/E RATIO
18.6
BETA
0.41
Less volatile
DIV YIELD
0.49%
52W HIGH
$821.11
52W LOW
$476.49
VOLATILITY
27.7%
30d annualized
Price Performance
30-DAY PRICE CHART
$771.25 → $770.79-0.06%
30 days agoToday
1-YEAR PERFORMANCE
$698.74 → $770.79+10.3%
REGN | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Regeneron Pharmaceuticals is currently trading at $770.79, which is 6.1% below its 52-week high. With a beta of 0.41, the stock shows lower sensitivity to market movements.
RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME0.8M(Below avg)
Frequently Asked Questions
Is REGN a good buy right now?
Regeneron Pharmaceuticals trades at 18.6x earnings. This is near market average. Current risk level is Medium based on 27.7% volatility.
Does REGN pay dividends?
Yes, Regeneron Pharmaceuticals offers a dividend yield of 0.49%. This translates to approximately $3.78 per share annually.
How volatile is REGN?
With 30-day annualized volatility of 27.7% and beta of 0.41,REGN is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track REGN Live
Add Regeneron Pharmaceuticals to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:38 PM